These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11115437)

  • 1. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
    Affrime MB; Kosoglou T; Thonoor CM; Flannery BE; Herron JM
    Chest; 2000 Dec; 118(6):1538-46. PubMed ID: 11115437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.
    Skoner DP; Meltzer EO; Milgrom H; Stryszak P; Teper A; Staudinger H
    J Asthma; 2011 Oct; 48(8):848-59. PubMed ID: 21854342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
    Kosoglou T; Cutler DL; Staudinger H; Herron JM
    Chest; 2010 Jan; 137(1):115-21. PubMed ID: 19749003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
    Noonan M; Leflein J; Corren J; Staudinger H
    BMC Pediatr; 2009 Jul; 9():43. PubMed ID: 19594937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
    Daley-Yates PT; Deans A; Mehta R; Sousa AR
    Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
    O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma.
    Skoner DP; Gentile DA; Angelini B
    Allergy Asthma Proc; 2010; 31(1):10-9. PubMed ID: 20167141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mometasone furoate (MF) improves lung function in pediatric asthma: A double-blind, randomized controlled dose-ranging trial of MF metered-dose inhaler.
    Amar NJ; Shekar T; Varnell TA; Mehta A; Philip G
    Pediatr Pulmonol; 2017 Mar; 52(3):310-318. PubMed ID: 27740721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
    Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
    Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T; Hubbell J; Xuan F; Cutler DL; Meehan AG; Kantesaria B; Wittmer BA
    Int J Chron Obstruct Pulmon Dis; 2013; 8():107-16. PubMed ID: 23525511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
    Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
    Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.
    Karpel JP; Nelson H
    Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.
    Nathan RA; Nayak AS; Graft DF; Lawrence M; Picone FJ; Ahmed T; Wolfe J; Vanderwalker ML; Nolop KB; Harrison JE
    Ann Allergy Asthma Immunol; 2001 Feb; 86(2):203-10. PubMed ID: 11258691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
    Szefler S; Rohatagi S; Williams J; Lloyd M; Kundu S; Banerji D
    Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A; Larivee P; Eller J; Cockcroft DW; Ghaly L; Harris AG
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.
    Noonan M; Karpel JP; Bensch GW; Ramsdell JW; Webb DR; Nolop KB; Lutsky BN
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):36-43. PubMed ID: 11206236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.
    Li JT; Goldstein MF; Gross GN; Noonan MJ; Weisberg S; Edwards L; Reed KD; Rogenes PR
    J Allergy Clin Immunol; 1999 Apr; 103(4):622-9. PubMed ID: 10200011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.